Track topics on Twitter Track topics that are important to you
Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, and Genethon, a non-profit R&D organization dedicated to the development of biotherapies for orphan genetic diseases from research to clinical validation, have signed a gene therapy research collaboration to jointly […]
The post Sarepta, Genethon collaborate for Duchenne muscular dystrophy appeared first on CenterWatch News Online.
Original Article: Sarepta, Genethon collaborate for Duchenne muscular dystrophyNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...